141 related articles for article (PubMed ID: 36590995)
21. Low-grade sulfadoxine-pyrimethamine resistance in Plasmodium falciparum parasites from Lubango, Angola.
Kaingona-Daniel EP; Gomes LR; Gama BE; Almeida-de-Oliveira NK; Fortes F; Ménard D; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
Malar J; 2016 Jun; 15():309. PubMed ID: 27267365
[TBL] [Abstract][Full Text] [Related]
22. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in western Kenya.
Lucchi NW; Okoth SA; Komino F; Onyona P; Goldman IF; Ljolje D; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
Antimicrob Agents Chemother; 2015 Jul; 59(7):3995-4002. PubMed ID: 25896703
[TBL] [Abstract][Full Text] [Related]
23. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
[TBL] [Abstract][Full Text] [Related]
24. Frequencies distribution of dihydrofolate reductase and dihydropteroate synthetase mutant alleles associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum population from Hadhramout Governorate, Yemen.
Bamaga OA; Mahdy MA; Lim YA
Malar J; 2015 Dec; 14():516. PubMed ID: 26693691
[TBL] [Abstract][Full Text] [Related]
25. Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
Enosse S; Magnussen P; Abacassamo F; Gómez-Olivé X; Rønn AM; Thompson R; Alifrangis M
Malar J; 2008 Jul; 7():115. PubMed ID: 18590577
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola.
Fortes F; Dimbu R; Figueiredo P; Neto Z; do Rosário VE; Lopes D
Malar J; 2011 Feb; 10():22. PubMed ID: 21288345
[TBL] [Abstract][Full Text] [Related]
27. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin.
Bertin G; Briand V; Bonaventure D; Carrieu A; Massougbodji A; Cot M; Deloron P
Malar J; 2011 Jul; 10():196. PubMed ID: 21767415
[TBL] [Abstract][Full Text] [Related]
28. High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania.
Matondo SI; Temba GS; Kavishe AA; Kauki JS; Kalinga A; van Zwetselaar M; Reyburn H; Kavishe RA
Malar J; 2014 Apr; 13():152. PubMed ID: 24751352
[TBL] [Abstract][Full Text] [Related]
29. High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin.
Moussiliou A; De Tove YS; Doritchamou J; Luty AJ; Massougbodji A; Alifrangis M; Deloron P; Ndam NT
Malar J; 2013 Jun; 12():195. PubMed ID: 23758883
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in the Democratic Republic of the Congo: emergence of highly resistant pfdhfr/pfdhps alleles.
Nkoli Mandoko P; Rouvier F; Matendo Kakina L; Moke Mbongi D; Latour C; Losimba Likwela J; Ngoyi Mumba D; Bi Shamamba SK; Tamfum Muyembe JJ; Muepu Tshilolo L; Parzy D; Sinou V
J Antimicrob Chemother; 2018 Oct; 73(10):2704-2715. PubMed ID: 30053021
[TBL] [Abstract][Full Text] [Related]
31. Sub-microscopic Plasmodium falciparum parasitaemia, dihydropteroate synthase (dhps) resistance mutations to sulfadoxine-pyrimethamine, transmission intensity and risk of malaria infection in pregnancy in Mount Cameroon Region.
Mbacham HF; Mosume DM; Apinjoh TO; Ntui VN; Moyeh MN; Kalaji LN; Wepnje GB; Ghogomu SM; Dionne JA; Tita ATN; Achidi EA; Anchang-Kimbi JK
Malar J; 2023 Mar; 22(1):73. PubMed ID: 36864514
[TBL] [Abstract][Full Text] [Related]
32. Molecular markers of resistance to amodiaquine plus sulfadoxine-pyrimethamine in an area with seasonal malaria chemoprevention in south central Niger.
Grais RF; Laminou IM; Woi-Messe L; Makarimi R; Bouriema SH; Langendorf C; Amambua-Ngwa A; D'Alessandro U; Guérin PJ; Fandeur T; Sibley CH
Malar J; 2018 Feb; 17(1):98. PubMed ID: 29486766
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms in pfdhfr and pfdhps genes after five years of artemisinin combination therapy (ACT) implementation from urban Kolkata, India.
Chatterjee M; Ganguly S; Saha P; Guha SK; Maji AK
Infect Genet Evol; 2017 Sep; 53():155-159. PubMed ID: 28533179
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in Plasmodium falciparum dihydropteroate synthetase and dihydrofolate reductase genes in Nigerian children with uncomplicated malaria using high-resolution melting technique.
Kayode AT; Ajogbasile FV; Akano K; Uwanibe JN; Oluniyi PE; Eromon PJ; Folarin OA; Sowunmi A; Wirth DF; Happi CT
Sci Rep; 2021 Jan; 11(1):471. PubMed ID: 33436791
[TBL] [Abstract][Full Text] [Related]
35. Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles.
Warsame M; Hassan AM; Barrette A; Jibril AM; Elmi HH; Arale AM; Mohammady HE; Nada RA; Amran JG; Muse A; Yusuf FE; Omar AS
Trop Med Int Health; 2015 Apr; 20(4):510-7. PubMed ID: 25583123
[TBL] [Abstract][Full Text] [Related]
36. Effect of three years' seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali.
Mahamar A; Sumner KM; Levitt B; Freedman B; Traore A; Barry A; Issiaka D; Dembele AB; Kanoute MB; Attaher O; Diarra BN; Sagara I; Djimde A; Duffy PE; Fried M; Taylor SM; Dicko A
Malar J; 2022 Feb; 21(1):39. PubMed ID: 35135546
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
Mugittu K; Ndejembi M; Malisa A; Lemnge M; Premji Z; Mwita A; Nkya W; Kataraihya J; Abdulla S; Beck HP; Mshinda H
Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
[TBL] [Abstract][Full Text] [Related]
38. Widespread resistance mutations to sulfadoxine-pyrimethamine in malaria parasites imported to China from Central and Western Africa.
Zhao L; Pi L; Qin Y; Lu Y; Zeng W; Xiang Z; Qin P; Chen X; Li C; Zhang Y; Wang S; Si Y; Yang G; Rosenthal BM; Huang Y; Yang Z
Int J Parasitol Drugs Drug Resist; 2020 Apr; 12():1-6. PubMed ID: 31809965
[TBL] [Abstract][Full Text] [Related]
39. Molecular monitoring of Plasmodium falciparum super-resistance to sulfadoxine-pyrimethamine in Tanzania.
Kavishe RA; Kaaya RD; Nag S; Krogsgaard C; Notland JG; Kavishe AA; Ishengoma D; Roper C; Alifrangis M
Malar J; 2016 Jun; 15():335. PubMed ID: 27339129
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.
Zakeri S; Afsharpad M; Raeisi A; Djadid ND
Malar J; 2007 Nov; 6():148. PubMed ID: 17999755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]